However, based on the clinical efficacy of these therapies, it is likely that early initiation of CFTR modulator therapy, effective symptom management and infection control, and regular airway clearance therapy all enhance the ability of individuals with CF to exercise. This evidence concerns the gene CFTR and cystic fibrosis.